US › Healthcare

Legend Biotech Corp (LEGN)

US · Healthcare · Biotechnology

$19.13+0.63%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$305.1M
Revenue YoY
+56.4%
Net profit
$-54.3M
Profit YoY
+46.2%
EPS
$-0.15
EPS estimate
$0.01
Net margin
-17.8%

EPS came in at -0.15 against a street estimate of 0.01 — a miss of 1113.5%.

Key statistics

Market cap
$3.59B
Forward P/E
123.5
P/B
3.71
Book value
$5.21
EPS (TTM)
$-1.38
52-week high
$39.16
52-week low
$16.24
50-day MA
$27.95
200-day MA
$24.54
Beta
0.34

Analyst view

Analysts rate Legend Biotech Corp a buy (21 buy, 1 hold, 0 sell out of 22) with an average price target of $52.10.

Shareholding

Insiders
1.25%
Institutions
54.04%

Largest institutional holders

FundStake
FMR Inc13.28%
Deerfield Management Co3.97%
Suvretta Capital Management, LLC3.92%
Hillhouse Capital Advisors, Ltd.3.09%
Westfield Capital Management Company, L.P.2.98%
BlackRock Inc2.42%
Point72 Asset Management, L.P.2.01%
Artisan Partners Limited Partnership1.17%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Legend Biotech Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.